RENEO PHARMACEUTICALS INC (RPHM) Stock Analyst Ratings
USA - NASDAQ:RPHM - US75974E1038 - Common Stock
1.82 USD
+0.09 (+5.2%)
1.81 USD
-0.01 (-0.55%)
ChartMill assigns a Buy % Consensus number of 46% to RPHM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.3. This target is 26.1% above the current price.
RPHM was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about RPHM.
In the previous month the buy percentage consensus was at a similar level.
RPHM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-12-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-15 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-15 | William Blair | Initiate | Outperform |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Initiate | Buy |
| 2023-07-03 | B of A Securities | Initiate | Buy |
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2022-01-27 | Baird | Initiate | Outperform |
| 2021-12-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-22 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-04 | SVB Leerink | Initiate | Outperform |
| 2021-05-04 | Piper Sandler | Initiate | Overweight |
| 2021-05-04 | Jefferies | Initiate | Buy |
RENEO PHARMACEUTICALS INC / RPHM FAQ
Can you provide the average price target for RENEO PHARMACEUTICALS INC stock?
7 analysts have analysed RPHM and the average price target is 2.3 USD. This implies a price increase of 26.1% is expected in the next year compared to the current price of 1.82.
Can you provide the consensus rating for RENEO PHARMACEUTICALS INC stock?
The consensus rating for RENEO PHARMACEUTICALS INC (RPHM) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.